Optimal sequential designs in phase I studies

DOI10.1016/J.CSDA.2013.05.010zbMath1471.62019OpenAlexW2039703052MaRDI QIDQ1621308

David Azriel

Publication date: 8 November 2018

Published in: Computational Statistics and Data Analysis (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.csda.2013.05.010

zbMATH Keywords

dynamic programmingsequential methodsoptimal designsphase I studies

Mathematics Subject Classification ID

Computational methods for problems pertaining to statistics (62-08) Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical design (62L05)

Related Items (1)

A continual reassessment method without undue risk of toxicity

Cites Work

• Unnamed Item
• Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
• A note on the robustness of the continual reassessment method
• The treatment versus experimentation dilemma in dose finding studies
• Approximate dynamic programming and its applications to the design of Phase I cancer trials
• Optimal Bayesian-feasible dose escalation for cancer phase I trials
• Sequential Monte Carlo for Bayesian sequentially designed experiments for discrete data
• Incorporating Individual and Collective Ethics into Phase I Cancer Trial Designs
• A Simple Technique to Evaluate Model Sensitivity in the Continual Reassessment Method
• Bayesian Optimal Designs for Phase I Clinical Trials

This page was built for publication: Optimal sequential designs in phase I studies